#1 Clinical Trials Search in Europe

Coffee Charcoal

Recent clinical trials have been exploring the potential of Coffee Charcoal, in combination with other natural ingredients, as a treatment for Irritable Bowel Syndrome (IBS). These studies focus on the efficacy and safety of MYRRHINIL-INTEST®, a medication containing Coffee Charcoal, Myrrh, and Chamomile extract, in managing symptoms of diarrhea-predominant IBS (IBS-D) and mixed-type IBS (IBS-M). The trials aim to provide valuable insights into this alternative treatment approach for patients suffering from these challenging gastrointestinal conditions.

Table of Contents

What is Coffee Charcoal?

Coffee charcoal, also known as Coffeae carbo, is a medicinal ingredient derived from coffee beans that have been processed into a charcoal form. It is one of the key components in a medication called MYRRHINIL-INTEST®, which is being studied for its potential benefits in treating certain digestive disorders.[1][2]

Medical Conditions Treated

MYRRHINIL-INTEST®, which contains coffee charcoal, is primarily being investigated for the treatment of two types of Irritable Bowel Syndrome (IBS):

  • Diarrhea-predominant IBS (IBS-D): A condition characterized by frequent loose or watery stools.
  • Mixed-type IBS (IBS-M): A condition where patients experience both diarrhea and constipation.

These conditions are chronic digestive disorders that can significantly impact a person’s quality of life, causing symptoms such as abdominal pain, changes in bowel habits, and bloating.[1][2]

Composition and Formulation

MYRRHINIL-INTEST® is a combination medication that includes three main ingredients:

  • Coffee charcoal: 50 mg
  • Myrrh: 100 mg
  • Dry extract from chamomile flower: 70 mg

The medication comes in the form of coated tablets, which are designed to be taken orally.[1][2]

How It Works

While the exact mechanism of action is still being studied, it is believed that the combination of coffee charcoal, myrrh, and chamomile extract works together to alleviate IBS symptoms. Coffee charcoal may help absorb excess gas and toxins in the digestive tract, while myrrh and chamomile are known for their anti-inflammatory and soothing properties.[1][2]

Dosage and Administration

According to the clinical trials, the maximum daily dose of MYRRHINIL-INTEST® is 12 coated tablets. The total treatment period in the studies lasted up to 8 weeks. However, it’s important to note that this dosage is specific to the clinical trials and may not reflect the final recommended dosage if the medication becomes approved for general use.[1][2]

Clinical Trials

MYRRHINIL-INTEST® is currently being evaluated in controlled clinical trials to investigate its efficacy and safety for patients with IBS-D and IBS-M. These trials aim to determine whether the medication can effectively reduce abdominal pain, improve stool consistency, and enhance overall bowel health compared to a placebo.[1][2]

Potential Benefits

If proven effective, MYRRHINIL-INTEST® could offer several benefits for IBS patients:

  • Reduction in abdominal pain
  • Improvement in stool consistency
  • Decrease in the frequency of diarrhea episodes
  • Better overall bowel health
  • Improved quality of life for those suffering from IBS-D or IBS-M

However, it’s important to remember that these potential benefits are still being evaluated in clinical trials.[1][2]

Side Effects and Precautions

As with any medication, there may be potential side effects and precautions to consider. The clinical trials are designed to assess the safety and tolerability of MYRRHINIL-INTEST®. Patients with known hypersensitivity to any of the ingredients (coffee charcoal, myrrh, or chamomile) should not take this medication. Additionally, the trials exclude patients with certain medical conditions, such as inflammatory bowel diseases, to ensure the safety of participants.[1][2]

It’s crucial to note that MYRRHINIL-INTEST® is still under investigation, and its full safety profile and efficacy have not yet been established. Patients should always consult with their healthcare provider before considering any new treatment for IBS or other digestive disorders.

Aspect Details
Study Drug MYRRHINIL-INTEST® (containing Coffee Charcoal, Myrrh, and Chamomile extract)
Target Conditions Diarrhea-predominant IBS (IBS-D) and Mixed-type IBS (IBS-M)
Participant Age Range 18-75 years
Primary Objectives Assess efficacy, safety, and tolerability compared to placebo
Key Measurements Abdominal pain, stool consistency, quality of life, global improvement
Study Duration Up to 8 weeks of treatment
Dosage Up to 12 coated tablets daily
Key Exclusions Inflammatory bowel diseases, diabetes, thyroid disorders, pregnancy

FAQ

  • What is Coffee Charcoal and how is it used in these clinical trials? Coffee Charcoal is one of the active ingredients in MYRRHINIL-INTEST®, along with Myrrh and Chamomile extract. In these trials, it's being studied as part of a treatment for Irritable Bowel Syndrome, specifically for diarrhea-predominant (IBS-D) and mixed-type (IBS-M) forms of the condition.
  • Who can participate in these clinical trials? Participants must be between 18 and 75 years old, diagnosed with IBS-D or IBS-M according to Rome IV criteria, and meet specific symptom requirements. They should not have certain other medical conditions like inflammatory bowel diseases, diabetes, or thyroid disorders. Pregnant women and those with recent antibiotic use are also excluded.
  • What are the main goals of these clinical trials? The primary objectives are to evaluate the efficacy, safety, and tolerability of MYRRHINIL-INTEST® compared to a placebo in treating IBS-D and IBS-M. The trials aim to assess improvements in abdominal pain, stool consistency, and overall bowel health.
  • How is the effectiveness of the treatment measured? Effectiveness is measured through various means, including changes in abdominal pain intensity, stool frequency and consistency, quality of life assessments, and global impressions of improvement. Participants keep daily diaries and complete questionnaires during regular study visits.
  • What are the potential benefits and risks of participating in these trials? Potential benefits include possible improvement in IBS symptoms and contributing to medical research. Risks may include side effects from the medication, which are being monitored throughout the trials. All participants are closely supervised by medical professionals to ensure safety.

Ongoing Clinical Trials on Coffee Charcoal

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated drugs:
    Germany

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Predominant Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated drugs:
    Germany

Glossary

  • Irritable Bowel Syndrome (IBS): A common disorder affecting the large intestine, characterized by abdominal pain and changes in bowel habits.
  • IBS-D: Diarrhea-predominant Irritable Bowel Syndrome, where loose, watery stools are the primary symptom.
  • IBS-M: Mixed-type Irritable Bowel Syndrome, where patients experience both diarrhea and constipation.
  • Rome IV criteria: A set of diagnostic criteria used to identify and classify functional gastrointestinal disorders, including IBS.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a real treatment.
  • Bristol Stool Form Scale: A medical tool used to classify the form of human feces into seven categories.
  • IBS-SSS: IBS Severity Scoring System, a questionnaire used to assess the severity of IBS symptoms.
  • IBS-QoL: IBS Quality of Life questionnaire, used to measure the impact of IBS on a patient's quality of life.
  • NRS pain: Numerical Rating Scale for pain, used to measure pain intensity on a scale from 0 to 10.
  • PGI-I scale: Patient Global Impression of Improvement scale, used to assess overall changes in a patient's condition.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-myrrh-coffee-charcoal-and-chamomile-extract-for-patients-with-diarrhea-predominant-irritable-bowel-syndrome/
  2. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-myrrh-coffee-charcoal-and-chamomile-extract-for-patients-with-diarrhea-dominant-or-mixed-type-irritable-bowel-syndrome/